คำอธิบาย
Quetiapine, a D2 receptor antagonist, pharmacodynamically opposes levodopa's dopaminergic effect, worsening Parkinson's disease motor symptoms.
กลไก
Levodopa is converted to dopamine and acts on striatal D2 receptors to improve Parkinsonism; quetiapine blocks D2 receptors, directly countering this therapeutic effect.
ความสำคัญทางคลินิก
Significant worsening of motor function (rigidity, bradykinesia, tremor) is expected when typical or atypical antipsychotics (except clozapine and pimavanserin) are used in Parkinson's disease.
การจัดการ
Avoid dopamine-blocking antipsychotics in Parkinson's disease; use clozapine or pimavanserin (low D2 affinity) for psychosis management.
ข้อจำกัดความรับผิดชอบทางการแพทย์
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.